1. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M. Quantitation of flavonoid constituents in citrus fruits. J Agric Food Chem. 1999;47(9):3565-3571.
2. Nogata Y, Sakamoto K, Shiratsuchi H, Ishii T, Yano M, Ohta H. Flavonoid composition of fruit tissues of citrus species. Biosci Biotechnol Biochem. 2006;70(1):178-192.
3. Lee C-H, Jeong T-S, Choi Y-K, Hyun B-H, Oh G-T, Kim E-H, et al. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun. 2001;284(3):681-688.
4. Verhoeyen M, Bovy A, Collins G, Muir S, Robinson S, De Vos C, et al. Increasing antioxidant levels in tomatoes through modification of the flavonoid biosynthetic pathway. J Exp Bot. 2002;53(377):2099-2106.
5. Arul D, Subramanian P. Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. Biochem Biophys Res Commun. 2013;434(2):203-209.
6. Jayachitra J, Nalini N. Effect of naringenin (citrus flavanone) on lipid profile in ethanol‐induced toxicity in rats. J Food Biochem. 2012;36(4):502-511.
7. Kumar SP, Birundha K, Kaveri K, Devi KR. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells. Int J Biol Macromol. 2015;78:87-95.
8. Hsiu S-L, Huang T-Y, Hou Y-C, Chin D-H, Chao P-DL. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci. 2002;70(13):1481-1489.
9. Yen F-L, Wu T-H, Lin L-T, Cham T-M, Lin C-C. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharm Res. 2009;26(4):893-902.
10. Ji P, Yu T, Liu Y, Jiang J, Xu J, Zhao Y, et al. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Drug Des Devel Ther. 2016;10:911.
11. Teixeira M, Pedro M, Nascimento MSJ, Pinto MM, Barbosa CM. Development and characterization of PLGA nanoparticles containing 1, 3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line. Pharm Dev Technol. 2019;24(9):1104-1114.
12. Simeonova S, Georgiev P, Exner KS, Mihaylov L, Nihtianova D, Koynov K, et al. Kinetic study of gold nanoparticles synthesized in the presence of chitosan and citric acid. Colloids Surf A Physicochem Eng Asp. 2018;557:106-115.
13. Crivelli B, Bari E, Perteghella S, Catenacci L, Sorrenti M, Mocchi M, et al. Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. Eur J Pharm Biopharm. 2019;137:37-45.
14. Krishnakumar N, Sulfikkarali N, RajendraPrasad N, Karthikeyan S. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomedicine & preventive nutrition. 2011;1(4):223-231.
15. Wen J, Liu B, Yuan E, Ma Y, Zhu Y. Preparation and physicochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin. Molecules. 2010;15(6):4401-4407.
16. Semalty A, Semalty M, Singh D, Rawat M. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem. 2010;67(3):253-260.
17. Zhang P, Liu X, Hu W, Bai Y, Zhang L. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Carbohydr Polym. 2016;149:224-230.
18. R. Price BG, Y. Lvov, R. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. J Microencapsul. 2001;18(6):713-722.
19. Veerabadran NG, Price RR, Lvov YM. Clay nanotubes for encapsulation and sustained release of drugs. Nano. 2007;2(02):115-120.
20. Wei W, Minullina R, Abdullayev E, Fakhrullin R, Mills D, Lvov Y. Enhanced efficiency of antiseptics with sustained release from clay nanotubes. RSC Adv. 2014;4(1):488-494.
21. Tan D, Yuan P, Annabi-Bergaya F, Yu H, Liu D, Liu H, et al. Natural halloysite nanotubes as mesoporous carriers for the loading of ibuprofen. Microporous Mesoporous Mater. 2013;179:89-98.
22. Lun H, Ouyang J, Yang H. Natural halloysite nanotubes modified as an aspirin carrier. RSC Adv. 2014;4(83):44197-44202.
23. Dionisi C, Hanafy N, Nobile C, De Giorgi ML, Rinaldi R, Casciaro S, et al. Halloysite clay nanotubes as carriers for curcumin: characterization and application. IEEE Trans Nanotechnol. 2016;15(5):720-724.
24. Hemmatpour H, Haddadi-Asl V, Roghani-Mamaqani H. Synthesis of pH-sensitive poly (N, N-dimethylaminoethyl methacrylate)-grafted halloysite nanotubes for adsorption and controlled release of DPH and DS drugs. Polymer. 2015;65:143-153.
25. Riela S, Massaro M, Colletti CG, Bommarito A, Giordano C, Milioto S, et al. Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. Int J Pharm. 2014;475(1-2):613-623.
26. Wang Q, Zhang J, Zheng Y, Wang A. Adsorption and release of ofloxacin from acid-and heat-treated halloysite. Colloids Surf B Biointerfaces. 2014;113:51-58.
27. Wang Q, Zhang J, Wang A. Alkali activation of halloysite for adsorption and release of ofloxacin. Appl Surf Sci. 2013;287:54-61.
28. Aguzzi C, Viseras C, Cerezo P, Salcedo I, Sánchez-Espejo R, Valenzuela C. Release kinetics of 5-aminosalicylic acid from halloysite. Colloids Surf B Biointerfaces. 2013;105:75-80.
29. Nyankson E, Aboagye SO, Efavi JK, Agyei-Tuffour B, Paemka L, Asimeng BO, et al. Chitosan-Coated Halloysite Nanotubes As Vehicle for Controlled Drug Delivery to MCF-7 Cancer Cells In Vitro. Materials (Basel). 2021;14(11):2837.
30. Liu M, Chang Y, Yang J, You Y, He R, Chen T, et al. Functionalized halloysite nanotube by chitosan grafting for drug delivery of curcumin to achieve enhanced anticancer efficacy. J Mater Chem B. 2016;4(13):2253-2263.
31. Muralidharan S, Shanmugam K. Synthesis and Characterization of Naringenin-Loaded Chitosan-Dextran Sulfate Nanocarrier. J Pharm Innov. 2021;16(2):269-278.
32. Cheng C, Gao Y, Song W, Zhao Q, Zhang H, Zhang H. Halloysite nanotube-based H2O2-responsive drug delivery system with a turn on effect on fluorescence for real-time monitoring. Chem Eng J. 2020;380:122474.
33. Pandey G, Munguambe DM, Tharmavaram M, Rawtani D, Agrawal Y. Halloysite nanotubes-An efficient ‘nano-support’for the immobilization of α-amylase. Appl Clay Sci. 2017;136:184-191.
34. Liu Y, Zhang J, Guan H, Zhao Y, Yang J-H, Zhang B. Preparation of bimetallic Cu-Co nanocatalysts on poly (diallyldimethylammonium chloride) functionalized halloysite nanotubes for hydrolytic dehydrogenation of ammonia borane. Appl Surf Sci. 2018;427:106-113.
35. Guan M, Shi R, Zheng Y, Zeng X, Fan W, Wang Y, et al. Characterization, in vitro and in vivo evaluation of naringenin-hydroxypropyl-β-cyclodextrin inclusion for pulmonary delivery. Molecules. 2020;25(3):554.
36. Rao KM, Nagappan S, Seo DJ, Ha C-S. pH sensitive halloysite-sodium hyaluronate/poly (hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery. Appl Clay Sci. 2014;97:33-42.
37. Barot T, Rawtani D, Kulkarni P. Development of chlorhexidine loaded halloysite nanotube based experimental resin composite with enhanced physico-mechanical and biological properties for dental applications. J Compos Sci. 2020;4(2):81.
38. Husain T, Shoaib MH, Ahmed FR, Yousuf RI, Farooqi S, Siddiqui F, et al. Investigating halloysite nanotubes as a potential platform for oral modified delivery of different BCS class drugs: characterization, optimization, and evaluation of drug release kinetics. Int J Nanomedicine. 2021;16:1725.
39. Gao M, Lu L, Wang X, Lin H, Zhou Q, editors. Preparation of a novel breviscapine-loaded halloysite nanotubes complex for controlled release of breviscapine. IOP Conf Ser Mater Sci Eng. 2017: IOP Publishing.
40. Siva Gangi Reddy N, Madhusudana Rao K, Park SY, Kim T, Chung I. Fabrication of aminosilanized halloysite based floating biopolymer composites for sustained gastro retentive release of curcumin. Macromol Res. 2019;27(5):490-496.
41. Permanadewi I, Kumoro A, Wardhani D, Aryanti N, editors. Modelling of controlled drug release in gastrointestinal tract simulation. J Phys Conf Ser. 2019: IOP Publishing.
42. Ghalandari B, Divsalar A, Komeili A, Eslami-Moghadam M, Saboury AA, Parivar K. Mathematical analysis of drug release for gastrointestinal targeted delivery using β-lactoglobulin nanoparticle. Biomacromol J. 2015;1(2):204-211.
43. Bediako EG, Nyankson E, Dodoo-Arhin D, Agyei-Tuffour B, Łukowiec D, Tomiczek B, et al. Modified halloysite nanoclay as a vehicle for sustained drug delivery. Heliyon. 2018;4(7).
44. Yamina AM, Fizir M, Itatahine A, He H, Dramou P. Preparation of multifunctional PEG-graft-halloysite nanotubes for controlled drug release, tumor cell targeting, and bio-imaging. Colloids Surf B Biointerfaces. 2018;170:322-329.
45. Hamedi S, Koosha M. Designing a pH-responsive drug delivery system for the release of black-carrot anthocyanins loaded in halloysite nanotubes for cancer treatment. Appl Clay Sci. 2020;197:105770.
46. Li W, Liu D, Zhang H, Correia A, Mäkilä E, Salonen J, et al. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy. Acta Biomater. 2017;48:238-246.
)